Clinical Supply Regulation Resources
-
Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials
5/12/2023
Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.
-
Building Robust Clinical Supply Chains To Support Global Trials
Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.
-
Overcome Vaccine Development Complexities With The Right Supply Chain Partner
7/5/2022
Explore the challenges impacting clinical supply chains and solutions to overcome these complexities, and understand why it is crucial to pick the right supply chain provider for vaccine storage and distribution.
-
Developing Injectable Drug Placebo Formulations For Clinical Trials
1/9/2024
Developing a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.
-
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution
9/20/2021
Analyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
Navigating New EU Clinical Trials Regulation Requirements For Clinical Supplies
Better understand Clinical Trials Regulation No. 536/201 (CTR) labeling changes and their potential to disrupt traditional clinical supply strategy that adhere to the new requirements.
-
A Smart Solution To Clinical Supply Management
10/28/2022
Delve into a solution that ensures the efficient delivery of trial materials worldwide, while navigating the challenges of more complex study designs and the ever-evolving regulatory landscape.
-
IQVIA Labeling Compliance Solutions
5/16/2023
Learn how by having a strategy for “core-to-carton” compliance, drug developers can avoid risks for patients and their company.
-
Sponsor Overcomes Hold And Steers Products Through Development
11/2/2023
Uncover how a small-sized biotech company was able to resolve critical regulatory CMC deficiencies to meet FDA requirements.
-
Strategies To Achieve Labeling Harmonization Amid A Legal Entity Change
3/9/2023
A strong labeling team is vital to ensure successful navigation of the legal entity change process, including developing a timeline, executing data transfers, and mitigating compliance risks.